Abstract HOXA5, a member of the HOX family, has been characterized as a tumor suppressor in several cancers. However, its regulation and role in oral cancer (OC) remain unclear. HOXA5 expression was assessed by transcriptome analysis and qRT-PCR, while methylation was evaluated using methyl-capture sequencing and bisulfite Sanger sequencing in a clinical cohort comprising OPMD, LN(-) and LN(+) groups and in vitro models.
Keith Hunter
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Keith
Contact Keith, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack